Literature DB >> 25252871

Mutational analysis of the DOK2 haploinsufficient tumor suppressor gene in chronic myelomonocytic leukemia (CMML).

E Coppin1, V Gelsi-Boyer1, X Morelli1, N Cervera1, A Murati1, P P Pandolfi2, D Birnbaum1, J A Nunès1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25252871     DOI： 10.1038/leu.2014.288

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  15 in total

1.  Gene expression profiling separates chronic myelomonocytic leukemia in two molecular subtypes.

Authors:  V Gelsi-Boyer; N Cervera; F Bertucci; V Trouplin; V Remy; S Olschwang; M Chaffanet; N Vey; M-J Mozziconacci; D Birnbaum
Journal:  Leukemia       Date:  2007-06-14       Impact factor: 11.528

Review 2.  The roles of Dok family adapters in immunoreceptor signaling.

Authors:  Ryuichi Mashima; Yukihiro Hishida; Tohru Tezuka; Yuji Yamanashi
Journal:  Immunol Rev       Date:  2009-11       Impact factor: 12.988

3.  Mutational analysis of DOK2 tumor suppressor gene in acute leukemias.

Authors:  Min Sung Kim; Nak Gyun Chung; Nam Jin Yoo; Sug Hyung Lee
Journal:  Leuk Res       Date:  2011-02-16       Impact factor: 3.156

4.  Phosphotyrosine binding-mediated oligomerization of downstream of tyrosine kinase (Dok)-1 and Dok-2 is involved in CD2-induced Dok phosphorylation.

Authors:  Iohann Boulay; Jean-Guy Némorin; Pascale Duplay
Journal:  J Immunol       Date:  2005-10-01       Impact factor: 5.422

5.  p56(dok-2) as a cytokine-inducible inhibitor of cell proliferation and signal transduction.

Authors:  S Suzu; M Tanaka-Douzono; K Nomaguchi; M Yamada; H Hayasawa; F Kimura; K Motoyoshi
Journal:  EMBO J       Date:  2000-10-02       Impact factor: 11.598

6.  Identification of DOK genes as lung tumor suppressors.

Authors:  Alice H Berger; Masaru Niki; Alessandro Morotti; Barry S Taylor; Nicholas D Socci; Agnes Viale; Cameron Brennan; Janos Szoke; Noriko Motoi; Paul B Rothman; Julie Teruya-Feldstein; William L Gerald; Marc Ladanyi; Pier Paolo Pandolfi
Journal:  Nat Genet       Date:  2010-02-07       Impact factor: 38.330

7.  Cutting edge: Dok-1 and Dok-2 adaptor molecules are regulated by phosphatidylinositol 5-phosphate production in T cells.

Authors:  Geoffrey Guittard; Audrey Gérard; Sophie Dupuis-Coronas; Hélène Tronchère; Eva Mortier; Cédric Favre; Daniel Olive; Pascale Zimmermann; Bernard Payrastre; Jacques A Nunès
Journal:  J Immunol       Date:  2009-04-01       Impact factor: 5.422

Review 8.  The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes.

Authors:  James W Vardiman; Jüergen Thiele; Daniel A Arber; Richard D Brunning; Michael J Borowitz; Anna Porwit; Nancy Lee Harris; Michelle M Le Beau; Eva Hellström-Lindberg; Ayalew Tefferi; Clara D Bloomfield
Journal:  Blood       Date:  2009-04-08       Impact factor: 22.113

Review 9.  Novel mutations and their functional and clinical relevance in myeloproliferative neoplasms: JAK2, MPL, TET2, ASXL1, CBL, IDH and IKZF1.

Authors:  A Tefferi
Journal:  Leukemia       Date:  2010-04-29       Impact factor: 11.528

10.  Role of Dok-1 and Dok-2 in myeloid homeostasis and suppression of leukemia.

Authors:  Tomoharu Yasuda; Masaki Shirakata; Atsushi Iwama; Asuka Ishii; Yasuhiro Ebihara; Mitsujiro Osawa; Kazuho Honda; Hisaaki Shinohara; Katsuko Sudo; Kohichiro Tsuji; Hiromitsu Nakauchi; Yoichiro Iwakura; Hisamaru Hirai; Hideaki Oda; Tadashi Yamamoto; Yuji Yamanashi
Journal:  J Exp Med       Date:  2004-12-20       Impact factor: 14.307
View more
  5 in total

1.  Genomic and Epigenomic Signatures in Ovarian Cancer Associated with Resensitization to Platinum Drugs.

Authors:  Fang Fang; Horacio Cardenas; Hao Huang; Guanglong Jiang; Susan M Perkins; Chi Zhang; Harold N Keer; Yunlong Liu; Kenneth P Nephew; Daniela Matei
Journal:  Cancer Res       Date:  2017-12-11       Impact factor: 12.701

Review 2.  Introduction to DOK2 and its potential role in cancer.

Authors:  P Sun; R Li; Y Meng; S Xi; Q Wang; X Yang; X Peng; J Cai
Journal:  Physiol Res       Date:  2021-09-10       Impact factor: 1.881

3.  Co-expression and significance of Dok2 and Ras p21 protein activator 1 in breast cancer.

Authors:  Jiangrong Huang; Xiaochun Peng; Kun Zhang; Chunyan Li; Bo Su; Yanxiang Zhang; Wangui Yu
Journal:  Oncol Lett       Date:  2017-08-28       Impact factor: 2.967

4.  Genomic analysis of a riboflavin-overproducing Ashbya gossypii mutant isolated by disparity mutagenesis.

Authors:  Tatsuya Kato; Junya Azegami; Ami Yokomori; Hideo Dohra; Hesham A El Enshasy; Enoch Y Park
Journal:  BMC Genomics       Date:  2020-04-23       Impact factor: 3.969

5.  Exome-wide analysis identifies three low-frequency missense variants associated with pancreatic cancer risk in Chinese populations.

Authors:  Jiang Chang; Jianbo Tian; Ying Zhu; Rong Zhong; Kan Zhai; Jiaoyuan Li; Juntao Ke; QiangQiang Han; Jiao Lou; Wei Chen; Beibei Zhu; Na Shen; Yi Zhang; Yajie Gong; Yang Yang; Danyi Zou; Xiating Peng; Zhi Zhang; Xuemei Zhang; Kun Huang; Ming Yang; Li Wang; Chen Wu; Dongxin Lin; Xiaoping Miao
Journal:  Nat Commun       Date:  2018-09-11       Impact factor: 14.919
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.